IDH1 Antibodies

Santa Cruz Biotechnology features a diverse variety of IDH1 monoclonal antibodies for various research applications. IDH1 monoclonal antibodies are compatible with western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Isocitrate dehydrogenase 1 (IDH1) plays a crucial role in cellular metabolism by catalyzing the conversion of isocitrate to alpha-ketoglutarate, a key step in the tricarboxylic acid (TCA) cycle. Mutations in the IDH1 gene are associated with various cancers, making it an important target for research in tumor biology and therapeutic development. Understanding the function and regulation of IDH1 is essential for elucidating metabolic pathways and their implications in disease. IDH1 monoclonal antibodies enable researchers to investigate cellular metabolism, cancer development, and potential therapeutic strategies. IDH1 monoclonal antibodies support detailed analysis of protein expression, localization, and interactions in various experimental settings. Santa Cruz Biotechnology monoclonal antibodies for IDH1 continue to advance scientific understanding of cellular metabolism and disease mechanisms, supporting researchers worldwide in their pursuit of breakthrough discoveries.